Tocilizumab is recommended for the treatment of severe COVID-19.
Título
Tocilizumab is recommended for the treatment of severe COVID-19.
Autor
Yonggang Zhou, Haiming Wei
Fecha
2020
Identificador
10.1016/j.ebiom.2020.103045
Fuente
EBioMedicine
Colección
Citación
Yonggang Zhou, Haiming Wei, “Tocilizumab is recommended for the treatment of severe COVID-19.,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/4963.
Position: 7994 (28 views)